Search Results - "Amato, Cristina"
-
1
-
2
A low power and real-time hardware recurrent neural network for time series analysis on wearable devices
Published in Microprocessors and microsystems (01-11-2021)“…The research presented in this paper addresses the exploitation of Deep Learning methods on wearable devices. We propose a hardware architecture capable of…”
Get full text
Journal Article -
3
Treatment with Oral Azacitidine in Elderly Patients with Higher Risk Myelodysplastic Syndromes after Response to Subcutaneous Azacitidine
Published in Blood (15-11-2022)Get full text
Journal Article -
4
The Combination of Decitabine Plus Venetoclax Is an Active Salvage Therapy for AML Post HR-MDS Progressed during Treatment with Azacitidine Based Regimens
Published in Blood (15-11-2022)Get full text
Journal Article -
5
Treatment of Elderly Patients with Higher Risk Myelodysplastic Syndromes with Oral Azacitidine
Published in Blood (02-11-2023)“…Background Oral formulations ofhypomethylating agents decitabine (ASTX727) and azacitidine (cc-486, AZA) were approved respectively for treatment of higher…”
Get full text
Journal Article -
6
PIEZO1 Mutation May Determine Early Onset of Clinical Manifestation of Anemia of Myelodysplastic Syndromes
Published in Blood (23-11-2021)“…Anemia is the most frequent cytopenia in myelodysplastic syndromes (MDS), neoplastic diseases characterized by ineffective hematopoiesis and bone marrow…”
Get full text
Journal Article -
7
Photoresponsive Polypeptides. Photomodulation of the Macromolecular Structure in Poly(N ε((phenylazophenyl)sulfonyl)-l-lysine)
Published in Macromolecules (17-06-1996)“…Poly(l-lysine) was reacted with p-phenylazobenzenesulfonyl chloride to give polypeptides containing azobenzene units linked to the Lys chains by means of…”
Get full text
Journal Article -
8
-
9
Impact of Mutational Burden and IPSS-M on Response to ESAs in Lower Risk Myelodysplastic Neoplasms
Published in Blood (02-11-2023)“…INTRODUCTION Lower risk myelodysplastic neoplasms (LR-MDS), as defined by IPSS-R, are frequently presenting with anemia which is primarily treated with…”
Get full text
Journal Article -
10
-
11
MDS-462 Response to Erythropoiesis-Stimulating Agent Therapy in IPSS-R Lower Risk Myelodysplastic Syndrome Patients Restratified According to IPSS-M
Published in Clinical lymphoma, myeloma and leukemia (01-09-2023)“…Erythropoiesis-stimulating agents (ESAs) are commonly used to treat anemic low-risk myelodysplastic syndrome (MDS) patients. Response to these agents is…”
Get full text
Journal Article -
12
PIEZO1 mutations impact on early clinical manifestations of myelodysplastic syndromes
Published in American journal of hematology (01-04-2023)Get full text
Journal Article -
13
MDS-223: Response to Erythroid Stimulating Agents (ESA) and Flow Cytometric Characteristics of Bone Marrow Erythroid Precursors in IPSS-R Lower-Risk Myelodysplastic Syndrome Patients
Published in Clinical lymphoma, myeloma and leukemia (01-09-2021)“…Standard treatment of anemia in lower-risk myelodysplastic syndromes (LR-MDS) is based on erythropoietic-stimulating agents (ESAs), but some patients are…”
Get full text
Journal Article -
14
-
15
Off-label use of drugs in Italy: a prospective, observational and multicentre study
Published in Acta pædiatrica (Oslo) (2002)“…The aims of the study were to measure the paediatric, off-label use of drugs in the Italian hospital setting and to reveal areas for priority intervention by…”
Get full text
Journal Article -
16
The association of rs4307059 and rs35678 markers with autism spectrum disorders is replicated in Italian families
Published in Psychiatric genetics (01-08-2012)“…The objective of this study was to replicate an association study on a newly collected Italian autism spectrum disorder (ASD) cohort by studying the genetic…”
Get full text
Journal Article -
17
Analysis of RBFOX1 gene expression in lymphoblastoid cell lines of Italian discordant autism spectrum disorders sib-pairs
Published in Molecular and cellular probes (01-10-2014)“…Several lines of evidence suggest that RBFOX1 is a key regulator of transcriptional and splicing programs in neural cells during development, and that it is…”
Get full text
Journal Article -
18
An Hardware Recurrent Neural Network for Wearable Devices
Published in 2020 23rd Euromicro Conference on Digital System Design (DSD) (01-08-2020)“…Automatic classification of time series signals acquired by wearable or portable devices covers a central role in many critical healthcare applications, such…”
Get full text
Conference Proceeding -
19
The inhibition of a leaf proteinase by l-lysine homopolymers
Published in Biochimica et biophysica acta (18-05-1995)“…The role of interlinked positively charged amino acids in the mechanism of inhibition of a monomeric trypsin-like proteinase has been investigated using high…”
Get full text
Journal Article